LifeMD, Inc. (LFMDP) Financial Statements (2025 and earlier)

Company Profile

Business Address 236 FIFTH AVENUE
NEW YORK, NY 10001
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 8011 - Offices and Clinics of Doctors of Medicine (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments33,1473,95941,3289,1791,107180
Cash and cash equivalent33,1473,95941,3289,1791,107180
Receivables5,2772,8359806489799
Inventory, net of allowances, customer advances and progress billings2,7603,7031,6171,2649501,023
Inventory2,7603,7031,6171,2649501,023
Deposits current assets486127204817  
Other current assets935687793155443270
Other undisclosed current assets     15033
Total current assets:42,60411,31144,92112,0632,7471,605
Noncurrent Assets
Operating lease, right-of-use asset5951,2061,75227424
Property, plant and equipment476476234   
Intangible assets, net (including goodwill)3,0093,832203406751,011
Intangible assets, net (excluding goodwill)3,0093,832203406751,011
Other undisclosed noncurrent assets11,7968,8402,996376  
Total noncurrent assets:15,87614,3545,0029906991,011
TOTAL ASSETS:58,48125,66649,92313,0543,4462,616
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:25,02222,27320,65511,7943,051869
Taxes payable2,000   
Employee-related liabilities1,658   
Accounts payable11,08510,1079,059   
Accrued liabilities13,93712,1677,066   
Other undisclosed accounts payable and accrued liabilities   87111,7943,051869
Deferred revenue8,8295,500  110
Debt3282,79763779815247
Other undisclosed current liabilities6038042,107917 76
Total current liabilities:34,78231,37422,82613,4903,9751,192
Noncurrent Liabilities
Long-term debt and lease obligation17,928 1,179  247
Long-term debt, excluding current maturities17,928    247
Liabilities, other than long-term debt2051,018100  4
Deferred tax liabilities, net4
Operating lease, liability745741,179  
Business combination, contingent consideration, liability131444100   
Other undisclosed noncurrent liabilities  579 385600353
Total noncurrent liabilities:18,1331,5971,279385600604
Total liabilities:52,91532,97124,10413,8754,5751,796
Commitments and contingencies     500600
Temporary equity, including noncontrolling interest  4,5664,1113,656(500)(600)
Equity
Equity, attributable to parent3,505(11,396)22,740(2,302)(988)898
Preferred stock000   
Common stock384316307234534458
Treasury stock, value(164)(164)(164)(164)(164)(164)
Additional paid in capital217,551179,015164,51877,77915,23612,744
Accumulated deficit(214,265)(190,563)(141,921)(80,152)(16,595)(12,141)
Equity, attributable to noncontrolling interest2,061(476)(1,032)(2,176)(141)(78)
Total equity:5,566(11,871)21,708(4,478)(1,129)820
TOTAL LIABILITIES AND EQUITY:58,48125,66649,92313,0543,4462,616

Income Statement (P&L) ($ in thousands)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues152,547119,03492,87637,29412,4698,324
Cost of revenue(18,900)(18,668)(17,995)(8,907)(3,271)(1,969)
Gross profit:133,647100,36574,88028,3869,1986,355
Operating expenses(148,136)(143,813)(129,181)(86,206)(12,088)(8,411)
Operating loss:(14,489)(43,448)(54,301)(57,819)(2,890)(2,056)
Nonoperating expense    (2,582)  
Interest and debt expense (2,922)(1,276)(7,015)(915)(761)(354)
Other undisclosed income from continuing operations before equity method investments, income taxes      926
Loss from continuing operations before equity method investments, income taxes:(17,411)(44,724)(61,316)(61,317)(3,651)(1,485)
Other undisclosed income (loss) from continuing operations before income taxes 63 915  
Loss from continuing operations before income taxes:(17,411)(44,660)(61,316)(60,402)(3,651)(1,485)
Income tax expense (benefit)(428)(361)(8)(123)123125
Loss from continuing operations:(17,839)(45,021)(61,324)(60,524)(3,528)(1,360)
Loss before gain (loss) on sale of properties:(61,324)(60,524)(3,528)(434)
Income from discontinued operations      926
Other undisclosed net loss      (926)
Net loss:(17,839)(45,021)(61,324)(60,524)(3,528)(1,360)
Net income (loss) attributable to noncontrolling interest(2,757)(515)4261,877391119
Net loss attributable to parent:(20,596)(45,536)(60,898)(58,647)(3,137)(1,241)
Preferred stock dividends and other adjustments(3,106)(3,106)(871)(4,716)  
Net loss available to common stockholders, diluted:(23,702)(48,642)(61,769)(63,363)(3,137)(1,241)

Comprehensive Income ($ in thousands)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(17,839)(45,021)(61,324)(60,524)(3,528)(1,360)
Comprehensive loss:(17,839)(45,021)(61,324)(60,524)(3,528)(1,360)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(2,757)(515)4261,877391119
Comprehensive loss, net of tax, attributable to parent:(20,596)(45,536)(60,898)(58,647)(3,137)(1,241)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: